Intranet
Solène Desmée | IAME
Solène Desmée - Former member -

Publications

Household costs of care in children under five attending primary care in Burkina Faso, Guinea, Mali and Niger: a cross-sectional study nested in the AIRE project

2025

DOI

Copy reference

BMJ global health

Agbeci H et al.Agbeci H, Bakyono R, Touré AO, Coulibaly A, Zair Z, Niome M, Hema A, Sawadogo AS, Keita S, Peters Bokol L, Hedible KGB, Neboua D, Louart S, Zombré V, Kaba DF, Sidibe A, Abarry Souleymane H, Cousien A, Busière S, Lamontagne F, Ridde V, Desmonde S, Leroy V, AIRE Research Study Group

Isatuximab-dexamethasone-pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II data

2024

DOI

Copy reference

CPT: pharmacometrics & systems pharmacology

Pitoy A et al.Pitoy A, Desmée S, Riglet F, Thai HT, Klippel Z, Semiond D, Veyrat-Follet C, Bertrand J

Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra-individual heterogeneity in patients with advanced cancer

2023

DOI

Copy reference

Biometrics

Kerioui M et al.Kerioui M, Beaulieu M, Desmée S, Bertrand J, Mercier F, Jin JY, Bruno R, Guedj J

Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?

2023

DOI

Copy reference

JCO precision oncology

Kerioui M et al.Kerioui M, Bertrand J, Desmée S, Le Tourneau C, Mercier F, Bruno R, Guedj J

Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models

2022

DOI

Copy reference

British Journal of Clinical Pharmacology

Kerioui M et al.Kerioui M, Bertrand J, Bruno R, Mercier F, Guedj J, Desmée S

Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy

2022

DOI

Copy reference

ESMO open

Kerioui M et al.Kerioui M, Desmée S, Mercier F, Lin A, Wu B, Jin JY, Shen X, Le Tourneau C, Bruno R, Guedj J

Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapy

2020

DOI

Copy reference

Statistics in Medicine

Kerioui M et al.Kerioui M, Mercier F, Bertrand J, Tardivon C, Bruno R, Guedj J, Desmée S

Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatment

2020

DOI

Copy reference

Journal of Pharmacokinetics and Pharmacodynamics

Mercier F et al.Mercier F, Kerioui M, Desmée S, Guedj J, Krieter O, Bruno R

Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow-Up

2019

DOI

Copy reference

Clinical Pharmacology and Therapeutics

Tardivon C et al.Tardivon C, Desmée S, Kerioui M, Bruno R, Wu B, Mentré F, Mercier F, Guedj J

Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients

2017

DOI

Copy reference

Biometrics

Desmée S et al.Desmée S, Mentré F, Veyrat-Follet C, Sébastien B, Guedj J

Nonlinear joint models for individual dynamic prediction of risk of death using Hamiltonian Monte Carlo: application to metastatic prostate cancer

2017

DOI

Copy reference

BMC Med Res Methodol

Desmee S et al.Desmee S, Mentre F, Veyrat-Follet C, Sebastien B, Guedj J

Nonlinear Mixed-effect Models for Prostate-specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: A Comparison by Simulation of Two-stage and Joint Approaches

2015

DOI

Copy reference

The AAPS journal

Desmée S et al.Desmée S, Mentré F, Veyrat-Follet C, Guedj J